JBS
MCID: JCB001
MIFTS: 48

Jacobsen Syndrome (JBS)

Categories: Blood diseases, Eye diseases, Fetal diseases, Rare diseases

Aliases & Classifications for Jacobsen Syndrome

MalaCards integrated aliases for Jacobsen Syndrome:

Name: Jacobsen Syndrome 57 75 53 25 59 13 40
Chromosome 11q Deletion Syndrome 57 53
Partial 11q Monosomy Syndrome 57 53
11q Partial Monosomy Syndrome 29 6
Jbs 57 53
Jacobsen Distal 11q Deletion Syndrome 72
Paris-Trousseau Thrombocytopenia 72
11q Terminal Deletion Disorder 25
Jacobsen Thrombocytopenia 25
Chromosome 11q Deletion 53
11q23 Deletion Disorder 25
11q- Deletion Syndrome 25
Telomeric Deletion 11q 59
11q Deletion Disorder 25
11q Deletion Syndrome 25
Partial Monosomy 11q 53
Distal Deletion 11q 59
Distal Monosomy 11q 59
Monosomy 11qter 59
Del(11)(q23.3) 59
Del(11)(qter) 59
11q Deletion 53
11q Monosomy 53
Deletion 11q 53
Monosomy 11q 53

Characteristics:

Orphanet epidemiological data:

59
jacobsen syndrome
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe); Age of onset: Antenatal,Neonatal;

OMIM:

57
Inheritance:
isolated cases

Miscellaneous:
contiguous gene deletion syndrome
75% of affected individuals are female
incidence of 1 in 100,000 births


HPO:

32
jacobsen syndrome:
Clinical modifier death in infancy
Inheritance sporadic


Classifications:



External Ids:

OMIM 57 147791
MESH via Orphanet 45 D054868
ICD10 via Orphanet 34 Q93.5
UMLS via Orphanet 73 C0795841
Orphanet 59 ORPHA2308
MedGen 42 C0795841
UMLS 72 C0795841 C1956093

Summaries for Jacobsen Syndrome

Genetics Home Reference : 25 Jacobsen syndrome is a condition caused by a loss of genetic material from chromosome 11. Because this deletion occurs at the end (terminus) of the long (q) arm of chromosome 11, Jacobsen syndrome is also known as 11q terminal deletion disorder. The signs and symptoms of Jacobsen syndrome vary considerably. Most affected individuals have delayed development, including the development of speech and motor skills (such as sitting, standing, and walking). Most also have cognitive impairment and learning difficulties. Behavioral problems have been reported, including compulsive behavior (such as shredding paper), a short attention span, and easy distractibility. Many people with Jacobsen syndrome have been diagnosed with attention-deficit/hyperactivity disorder (ADHD). Jacobsen syndrome is also associated with an increased likelihood of autism spectrum disorders, which are characterized by impaired communication and socialization skills. Jacobsen syndrome is also characterized by distinctive facial features. These include small and low-set ears, widely set eyes (hypertelorism) with droopy eyelids (ptosis), skin folds covering the inner corner of the eyes (epicanthal folds), a broad nasal bridge, downturned corners of the mouth, a thin upper lip, and a small lower jaw. Affected individuals often have a large head size (macrocephaly) and a skull abnormality called trigonocephaly, which gives the forehead a pointed appearance. More than 90 percent of people with Jacobsen syndrome have a bleeding disorder called Paris-Trousseau syndrome. This condition causes a lifelong risk of abnormal bleeding and easy bruising. Paris-Trousseau syndrome is a disorder of platelets, which are blood cell fragments that are necessary for blood clotting. Other features of Jacobsen syndrome can include heart defects, feeding difficulties in infancy, short stature, frequent ear and sinus infections, and skeletal abnormalities. The disorder can also affect the digestive system, kidneys, and genitalia. The life expectancy of people with Jacobsen syndrome is unknown, although affected individuals have lived into adulthood.

MalaCards based summary : Jacobsen Syndrome, also known as chromosome 11q deletion syndrome, is related to johanson-blizzard syndrome and hypoplastic left heart syndrome, and has symptoms including muscle spasticity An important gene associated with Jacobsen Syndrome is JBS (Jacobsen Syndrome), and among its related pathways/superpathways are NF-kappaB Signaling and CNTF Signaling. The drugs Fludarabine and rituximab have been mentioned in the context of this disorder. Affiliated tissues include heart, kidney and eye, and related phenotypes are intellectual disability and global developmental delay

NIH Rare Diseases : 53 Chromosome 11q deletion is a chromosome abnormality that occurs when there is a missing (deleted) copy of genetic material on the long arm (q) of chromosome 11. The severity of the condition and the signs and symptoms depend on the size and location of the deletion and which genes are involved. Features that often occur in people with chromosome 11q deletion include developmental delay, intellectual disability, behavioral problems and distinctive facial features. Chromosome testing of both parents can provide more information on whether or not the deletion was inherited. In most cases, parents do not have any chromosomal anomaly. However, sometimes one parent is found to have a balanced translocation, where a piece of a chromosome has broken off and attached to another one with no gain or loss of genetic material. The balanced translocation normally does not cause any signs or symptoms, but it increases the risk for having an affected child with a chromosomal anomaly like a deletion. Treatment is based on the signs and symptoms present in each person. This page is meant to provide general information about 11q deletions. You can contact GARD if you have questions about a specific deletion on chromosome 11. To learn more about chromosomal anomalies please visit our GARD webpage on FAQs about Chromosome Disorders.

Wikipedia : 75 Jacobsen syndrome is a rare chromosomal disorder resulting from deletion of genes from chromosome 11... more...

More information from OMIM: 147791

Related Diseases for Jacobsen Syndrome

Diseases related to Jacobsen Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 156)
# Related Disease Score Top Affiliating Genes
1 johanson-blizzard syndrome 12.2
2 hypoplastic left heart syndrome 11.6
3 thrombocytopenia, paris-trousseau type 11.4
4 thrombocytopenia 10.6
5 alacrima, achalasia, and mental retardation syndrome 10.4
6 bladder cancer 10.4
7 leukemia, chronic lymphocytic 10.3
8 lymphocytic leukemia 10.3
9 leukemia, b-cell, chronic 10.3
10 c syndrome 10.3
11 pancytopenia 10.3
12 chromosome 3p duplication 10.3
13 neuroblastoma 1 10.3
14 hypertelorism 10.3
15 fragile site 11b 10.3
16 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.3
17 peptic ulcer disease 10.3
18 strabismus 10.2
19 mechanical strabismus 10.2
20 chromosomal triplication 10.2
21 hypotonia 10.2
22 partial deletion of the long arm of chromosome 11 10.2
23 autism spectrum disorder 10.2
24 omphalocele 10.2
25 coloboma of macula 10.1
26 papillomatosis, confluent and reticulated 10.1
27 telecanthus 10.1
28 cryptorchidism, unilateral or bilateral 10.1
29 immune deficiency disease 10.1
30 ptosis 10.1
31 inguinal hernia 10.1
32 agammaglobulinemia 10.1
33 combined t cell and b cell immunodeficiency 10.1
34 otosclerosis 10.1
35 disease of mental health 10.1
36 cholecystitis 10.1
37 adenocarcinoma 10.1
38 anthrax disease 10.1
39 lung disease 10.1
40 back pain 10.1
41 central cord syndrome 10.1
42 rapidly involuting congenital hemangioma 10.1
43 autism 10.0
44 suppression amblyopia 10.0
45 amblyopia 10.0
46 leukodystrophy 10.0
47 hypothyroidism 10.0
48 ventricular septal defect 10.0
49 growth hormone deficiency 10.0
50 branchiootic syndrome 1 10.0

Graphical network of the top 20 diseases related to Jacobsen Syndrome:



Diseases related to Jacobsen Syndrome

Symptoms & Phenotypes for Jacobsen Syndrome

Human phenotypes related to Jacobsen Syndrome:

59 32 (show top 50) (show all 105)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 intellectual disability 59 32 hallmark (90%) Very frequent (99-80%) HP:0001249
2 global developmental delay 59 32 hallmark (90%) Very frequent (99-80%) HP:0001263
3 feeding difficulties in infancy 59 32 hallmark (90%) Very frequent (99-80%) HP:0008872
4 bone marrow hypocellularity 59 32 hallmark (90%) Very frequent (99-80%) HP:0005528
5 thrombocytopenia 59 32 hallmark (90%) Very frequent (99-80%) HP:0001873
6 macrocephaly 59 32 frequent (33%) Frequent (79-30%) HP:0000256
7 hypertelorism 59 32 frequent (33%) Frequent (79-30%) HP:0000316
8 short neck 59 32 frequent (33%) Frequent (79-30%) HP:0000470
9 frontal bossing 59 32 frequent (33%) Frequent (79-30%) HP:0002007
10 finger syndactyly 59 32 frequent (33%) Frequent (79-30%) HP:0006101
11 ptosis 59 32 frequent (33%) Frequent (79-30%) HP:0000508
12 constipation 59 32 frequent (33%) Frequent (79-30%) HP:0002019
13 recurrent respiratory infections 59 32 frequent (33%) Frequent (79-30%) HP:0002205
14 pes planus 59 32 frequent (33%) Frequent (79-30%) HP:0001763
15 short nose 59 32 frequent (33%) Frequent (79-30%) HP:0003196
16 smooth philtrum 59 32 frequent (33%) Frequent (79-30%) HP:0000319
17 anteverted nares 59 32 frequent (33%) Frequent (79-30%) HP:0000463
18 short stature 59 32 frequent (33%) Frequent (79-30%) HP:0004322
19 broad hallux phalanx 59 32 frequent (33%) Frequent (79-30%) HP:0010059
20 long philtrum 59 32 frequent (33%) Frequent (79-30%) HP:0000343
21 strabismus 59 32 frequent (33%) Frequent (79-30%) HP:0000486
22 epicanthus 59 32 frequent (33%) Frequent (79-30%) HP:0000286
23 toe clinodactyly 59 32 frequent (33%) Frequent (79-30%) HP:0001863
24 abnormal form of the vertebral bodies 59 32 frequent (33%) Frequent (79-30%) HP:0003312
25 cryptorchidism 59 32 frequent (33%) Frequent (79-30%) HP:0000028
26 attention deficit hyperactivity disorder 59 32 frequent (33%) Frequent (79-30%) HP:0007018
27 short toe 59 32 frequent (33%) Frequent (79-30%) HP:0001831
28 ventriculomegaly 59 32 frequent (33%) Frequent (79-30%) HP:0002119
29 low-set, posteriorly rotated ears 59 32 frequent (33%) Frequent (79-30%) HP:0000368
30 aplasia/hypoplasia of the earlobes 59 32 frequent (33%) Frequent (79-30%) HP:0009906
31 facial asymmetry 59 32 frequent (33%) Frequent (79-30%) HP:0000324
32 downslanted palpebral fissures 59 32 frequent (33%) Frequent (79-30%) HP:0000494
33 ventricular septal defect 59 32 frequent (33%) Frequent (79-30%) HP:0001629
34 high forehead 59 32 frequent (33%) Frequent (79-30%) HP:0000348
35 aplasia/hypoplasia of the eyebrow 59 32 frequent (33%) Frequent (79-30%) HP:0100840
36 toe syndactyly 59 32 frequent (33%) Frequent (79-30%) HP:0001770
37 microcornea 59 32 frequent (33%) Frequent (79-30%) HP:0000482
38 premature birth 59 32 frequent (33%) Frequent (79-30%) HP:0001622
39 missing ribs 59 32 frequent (33%) Frequent (79-30%) HP:0000921
40 long hallux 59 32 frequent (33%) Frequent (79-30%) HP:0001847
41 broad columella 59 32 frequent (33%) Frequent (79-30%) HP:0010761
42 agenesis of corpus callosum 59 32 occasional (7.5%) Occasional (29-5%) HP:0001274
43 seizures 59 32 occasional (7.5%) Occasional (29-5%) HP:0001250
44 scoliosis 59 32 occasional (7.5%) Occasional (29-5%) HP:0002650
45 inguinal hernia 59 32 occasional (7.5%) Occasional (29-5%) HP:0000023
46 cataract 59 32 occasional (7.5%) Occasional (29-5%) HP:0000518
47 wide nasal bridge 59 32 occasional (7.5%) Occasional (29-5%) HP:0000431
48 intrauterine growth retardation 59 32 occasional (7.5%) Occasional (29-5%) HP:0001511
49 webbed neck 59 32 occasional (7.5%) Occasional (29-5%) HP:0000465
50 coarctation of aorta 59 32 occasional (7.5%) Occasional (29-5%) HP:0001680

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Head:
macrocephaly
microcephaly
trigonocephaly
flat occiput

Head And Neck Ears:
low-set ears

Chest Ribs Sternum Clavicles And Scapulae:
pectus excavatum
missing ribs

Growth Other:
failure to thrive
intrauterine growth retardation

Head And Neck Face:
micrognathia

Cardiovascular Heart:
atrial septal defect
ventricular septal defect

Genitourinary External Genitalia Male:
hypospadias

Skeletal Hands:
brachydactyly
fifth finger clinodactyly

Abdomen Pancreas:
annular pancreas

Skeletal Limbs:
joint contractures

Head And Neck Mouth:
large, carp-shaped mouth

Head And Neck Eyes:
hypertelorism
ptosis
optic atrophy
strabismus
telecanthus
more
Head And Neck Neck:
short neck

Neurologic Central Nervous System:
hydrocephalus
spasticity
holoprosencephaly
mental retardation
hypotonia (infancy)

Head And Neck Nose:
depressed nasal bridge
short nose
upturned nasal tip

Genitourinary Internal Genitalia Male:
cryptorchidism

Hematology:
thrombocytopenia

Genitourinary External Genitalia Female:
labial hypoplasia
clitoral hypoplasia

Abdomen Gastrointestinal:
pyloric stenosis

Respiratory:
frequent respiratory infections

Skin Nails Hair Hair:
abnormal eyelashes
abnormal eyebrows

Laboratory Abnormalities:
partial deletion of long arm of chromosome 11 (11q23-qter)

Clinical features from OMIM:

147791

UMLS symptoms related to Jacobsen Syndrome:


muscle spasticity

MGI Mouse Phenotypes related to Jacobsen Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.02 BSX CBL ETS1 FLI1 JAK3

Drugs & Therapeutics for Jacobsen Syndrome

Drugs for Jacobsen Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 17)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Fludarabine Approved Phase 3 21679-14-1, 75607-67-9 30751
2
rituximab Approved Phase 3 174722-31-7 10201696
3
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
4 Immunologic Factors Phase 3
5 Antineoplastic Agents, Immunological Phase 3
6 Antirheumatic Agents Phase 3
7
Vidarabine Approved, Investigational Phase 2 24356-66-9 21704 32326
8
Lenalidomide Approved Phase 2 191732-72-6 216326
9
Metformin Approved Phase 2 657-24-9 4091 14219
10 Angiogenesis Inhibitors Phase 2
11 Angiogenesis Modulating Agents Phase 2
12 Anti-Infective Agents Phase 2
13 Immunosuppressive Agents Phase 2
14 Antiviral Agents Phase 2
15 Antimetabolites Phase 2
16 Antimetabolites, Antineoplastic Phase 2
17 Hypoglycemic Agents Phase 2

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Single-agent Rituximab as Maintenance Treatment Versus Observation After Combined Induction Immunochemotherapy With Fludarabine, Cyclophosphamide and Rituximab in Patients Older Than 65 Years With Previously Untreated Chronic Lymphocytic Leukemia: a Phase III Trial of FILO Completed NCT00645606 Phase 3
2 Lenalidomide Following Rituximab and Fludarabine in Untreated Chronic Lymphocytic Leukemia Completed NCT00860457 Phase 2 Rituximab;Fludarabine;Lenalidomide
3 A Phase II Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia and Untreated CLL Patients With Genomic Deletion 11q Recruiting NCT01750567 Phase 2 Metformin

Search NIH Clinical Center for Jacobsen Syndrome

Genetic Tests for Jacobsen Syndrome

Genetic tests related to Jacobsen Syndrome:

# Genetic test Affiliating Genes
1 11q Partial Monosomy Syndrome 29

Anatomical Context for Jacobsen Syndrome

MalaCards organs/tissues related to Jacobsen Syndrome:

41
Heart, Kidney, Eye, Testes, Skin, Bone, Bone Marrow

Publications for Jacobsen Syndrome

Articles related to Jacobsen Syndrome:

(show top 50) (show all 140)
# Title Authors PMID Year
1
Diagnosis and fine mapping of a deletion in distal 11q in two Chinese patients with developmental delay. 38 8
20520618 2010
2
Transverse limb defect in a patient with Jacobsen syndrome: concurrence of malformation and disruption. 38 8
20358622 2010
3
Deletion of ETS-1, a gene in the Jacobsen syndrome critical region, causes ventricular septal defects and abnormal ventricular morphology in mice. 38 8
19942620 2010
4
Deletion of JAM-C, a candidate gene for heart defects in Jacobsen syndrome, results in a normal cardiac phenotype in mice. 38 8
19533782 2009
5
Chromosomal microarray mapping suggests a role for BSX and Neurogranin in neurocognitive and behavioral defects in the 11q terminal deletion disorder (Jacobsen syndrome). 38 8
18855024 2009
6
Clinical and molecular-cytogenetic evaluation of a family with partial Jacobsen syndrome without thrombocytopenia caused by an approximately 5 Mb deletion del(11)(q24.3). 38 8
18792974 2008
7
Sleep problems in individuals with 11q terminal deletion disorder (Jacobsen syndrome). 38 8
18618998 2008
8
Jacobsen syndrome and Beckwith-Wiedemann syndrome caused by a parental pericentric inversion inv(11)(p15q24). 38 8
17044870 2006
9
The ocular manifestations of Jacobsen syndrome: a report of four cases and a review of the literature. 38 8
16543195 2006
10
Further delineation of the phenotype maps for partial trisomy 16q24 and Jacobsen syndrome by a subtle familial translocation t(11;16)(q24.2;q24.1). 38 8
16222663 2005
11
The 11q terminal deletion disorder: a prospective study of 110 cases. 38 8
15266616 2004
12
Endocrine abnormalities in patients with Jacobsen (11q-) syndrome. 38 8
15266617 2004
13
Primary immunodeficiency in combination with transverse upper limb defect and anal atresia in a 34-year-old patient with Jacobsen syndrome. 38 8
15054845 2004
14
Giant platelets in a case of deletion 11q24-qter confirmed by fluorescence in situ hybridization. 38 8
12116256 2002
15
Paris-Trousseau syndrome platelets in a child with Jacobsen's syndrome. 38 8
11279643 2001
16
Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: evidence for a common mechanism of chromosome breakage. 38 8
10767345 2000
17
Molecular analysis of a translocation (6;11)(p21;q25) in a girl with Jacobsen syndrome. 38 8
10494099 1999
18
Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B. 38 8
9508241 1998
19
Jacobsen syndrome: report of a patient with severe eye anomalies, growth hormone deficiency, and hypothyroidism associated with deletion 11 (q23q25) and review of 52 cases. 38 8
8880580 1996
20
Clinical and molecular characterization of patients with distal 11q deletions. 38 8
7887422 1995
21
Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. 38 8
7881408 1994
22
Molecular detection of a translocation (Y;11) (q11.2;q24) in a 45,X male with signs of Jacobsen syndrome. 38 8
1551671 1992
23
Novel clinical features in a child with partial deletion of chromosome 11 [del(11)(q24.2)]: further evidence for phenotypic heterogeneity. 8
16411193 2006
24
Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases. 8
14597985 2003
25
Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. 8
10981960 2000
26
Two craniosynostotic patients with 11q deletions, and review of 48 cases. 8
8588585 1995
27
Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. 8
7603564 1995
28
Deletion 11q23.3 without familial predisposition. 8
3169750 1988
29
Chromosome deletion at 11q23 in an abnormal child from a family with inherited fragility at 11q23. 8
3610150 1987
30
Distal 11q monosomy. The typical 11q monosomy syndrome is due to deletion of subband 11q24.1. 8
3791674 1986
31
An (11;21) translocation in four generations with chromosome 11 abnormalities in the offspring. A clinical, cytogenetical, and gene marker study. 8
4134631 1973
32
[Prenatal diagnosis of Jacobsen syndrome in a fetus carried by a pregnant woman with intellectual disability]. 38
31400138 2019
33
Partial Jacobsen syndrome phenotype in a patient with a de novo frameshift mutation in the ETS1 transcription factor. 38
31160359 2019
34
11q24.2q24.3 microdeletion in two families presenting features of Jacobsen syndrome, without intellectual disability: Role of FLI1, ETS1, and SENCR long noncoding RNA. 38
30888095 2019
35
Successful Management of a Patient With Jacobsen Syndrome and Hypoplastic Left Heart Syndrome. 38
31117916 2019
36
Teaching NeuroImages: A rare case of Jacobsen syndrome with global diffuse hypomyelination of brain. 38
30936237 2019
37
Two siblings with 11qter deletion syndrome that had been rescued in their mother by uniparental disomy. 38
30031150 2019
38
Gene-targeted deletion in mice of the Ets-1 transcription factor, a candidate gene in the Jacobsen syndrome kidney "critical region," causes abnormal kidney development. 38
30422383 2019
39
Neph2/Kirrel3 regulates sensory input, motor coordination, and home-cage activity in rodents. 38
30133126 2018
40
Ventriculomegaly and cerebellar hypoplasia in a neonate with interstitial 11q 24 deletion in Jacobsen syndrome region. 38
29988670 2018
41
Craniosynostosis as a clinical and diagnostic problem: molecular pathology and genetic counseling. 38
29392564 2018
42
11q23 deletion syndrome (Jacobsen syndrome) with severe bleeding: a case report. 38
29307309 2018
43
FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology. 38
28432223 2017
44
Brain hemorrhages in Jacobsen syndrome: A retrospective review of six cases and clinical recommendations. 38
28211970 2017
45
Molecular cytogenetic characterization of Jacobsen syndrome (11q23.3-q25 deletion) in a fetus associated with double outlet right ventricle, hypoplastic left heart syndrome and ductus venosus agenesis on prenatal ultrasound. 38
28254208 2017
46
Complex Mosaic Ring Chromosome 11 Associated with Hemizygous Loss of 8.6 Mb of 11q24.2qter in Atypical Jacobsen Syndrome. 38
28232783 2017
47
Increased Excitatory Synaptic Transmission of Dentate Granule Neurons in Mice Lacking PSD-95-Interacting Adhesion Molecule Neph2/Kirrel3 during the Early Postnatal Period. 38
28381988 2017
48
Morphological and genetic abnormalities in a Jacobsen syndrome. 38
29556653 2017
49
11q terminal deletion and combined immunodeficiency (Jacobsen syndrome): Case report and literature review on immunodeficiency in Jacobsen syndrome. 38
27605496 2016
50
Jacobsen syndrome, Braddock-Carey syndrome, and Beyond: Reflections on intellectual disability accompanied with thrombocytopenia. 38
27569865 2016

Variations for Jacobsen Syndrome

ClinVar genetic disease variations for Jacobsen Syndrome:

6
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 covers 53 genes, none of which curated to show dosage sensitivity GRCh37/hg19 11q24.2-25(chr11: 125446101-134904063) copy number loss Pathogenic 11:125446101-134904063 :0-0
2 ACAD8 ; GLB1L3 ; IGSF9B ; JAM3 ; LINC02743 ; NCAPD3 ; OPCML ; SPATA19 ; THYN1 ; VPS26B GRCh37/hg19 11q25(chr11: 133325079-134157243) copy number loss Pathogenic 11:133325079-134157243 :0-0
3 ETS1 NM_001143820.2(ETS1): c.1044_1049delinsTT (p.Lys349fs) indel Pathogenic 11:128350160-128350165 11:128480265-128480270

Expression for Jacobsen Syndrome

Search GEO for disease gene expression data for Jacobsen Syndrome.

Pathways for Jacobsen Syndrome

Pathways related to Jacobsen Syndrome according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.85 JAK3 FLI1 CBL
2
Show member pathways
11.47 JAK3 ETS1 CBL
3 10.6 JAK3 ETS1 CBL

GO Terms for Jacobsen Syndrome

Biological processes related to Jacobsen Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 locomotory behavior GO:0007626 8.65 BSX
2 positive regulation of long-term synaptic potentiation GO:1900273 8.62 SHANK3 NRGN

Sources for Jacobsen Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....